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Abstract Matrix metalloproteinase (MMP) activation is an
essential feature of pathological and physiological arterial
enlargement or shrinkage. Recently, furin-activated membrane
type-1 MMP (MT1-MMP) was identified as the in vivo
activator of MMP2 in mice. Although arterial enlargement
and shrinkage are important in several pathological processes,
this proprotein convertase^MT1-MMP axis has not been
described during arterial remodeling. In rabbit femoral and
carotid arteries, we report an increase in furin and MT1-MMP
mRNA levels before and at the onset of arterial remodeling
followed by an increase in activated MMP2. This reveals the
presence of the proprotein convertase^MT1-MMP axis in flow-
induced arterial remodeling and identifies furin as a possible
target for local intervention in pathological arterial remodel-
ing. ß 2001 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Degradation and resynthesis of the extracellular matrix are
essential during tissue remodeling. Matrix turnover is neces-
sary for physiological and pathological processes to occur,
such as cell migration, angiogenesis, tumor cell invasion and
wound healing.
In arteries, remodeling of the arterial wall varies from arte-
rial enlargement to shrinkage and determines the luminal nar-
rowing after balloon angioplasty [1^3], in atherosclerosis [4,5]
and during sustained blood £ow changes [6].
The major extracellular component of the arterial wall is
collagen. Together with other proteins, collagen forms a struc-
tural protein network, that is rigid and resistant to proteolytic
digestion. The only proteinases able to cleave collagen are
matrix metalloproteinases (MMPs). These prove to play an
essential role in arterial remodeling since MMP inhibitors
prevent arterial remodeling after sustained £ow changes and
balloon injury [7^9].
MMPs are mostly synthesized as inactive zymogens
(proMMPs) and their activation by proteolytic cleavage is a
rate-limiting step for their catalytic function. Membrane type-
1 MMP (MT1-MMP) is a membrane-anchored MMP and has
a pivotal function in connective tissue metabolism [10,11] and
activation of proMMP2 [12].
MT1-MMP is activated after cleavage by a proprotein con-
vertase [13,14] and activation results in a stimulation of
proMMP2 cleavage generating the activated MMP2. In tis-
sues from MT1-MMP null mice, activation of MMP2 was
de¢cient suggesting that MT1-MMP is essential for its activa-
tion in vivo [11].
In vitro studies show that the proprotein convertase^MT1-
MMP^MMP2 axis plays a major role in regulating complex
arrays of proteolytic activities [15]. However, in arteries this
MMP activation axis has not yet been described. MMP acti-
vation is assumed to play an important role in arterial geo-
metrical remodeling. We therefore hypothesized that the pro-
protein convertase^MT1-MMP expression precedes MMP2
activation and subsequent arterial remodeling.
MMP activity is associated with in£ux of macrophages [16]
and neointima formation [17] which may occur simulta-
neously with arterial restructuring. In this study, we induced
arterial remodeling without neointima formation and in£am-
mation by sustained £ow increase or decrease in rabbit carotid
and femoral arteries. We observed an increase in arterial furin
and MT1-MMP expression that preceded or coincided with
the increase in arterial MMP2 activation during arterial re-
modeling. This revealed the presence of the proprotein con-
vertase^MT1-MMP^MMP2 axis in arteries and opens a new
therapeutic potential in the treatment of arterial luminal nar-
rowing by speci¢c proprotein convertase inhibitors.
2. Materials and methods
2.1. Animals
Fifty New Zealand White rabbits (Broekman Charles River, 3^3.5
kg) were used. The rabbits were anesthetized by intramuscular injec-
tion of methadone (0.15 ml) and vetranquil (0.15 ml) followed by
intravenous injection of etomidate (1 mg/kg) and ventilation with
N2O:O2/0.6% halothane.
To increase £ow (n = 23), a side-to-side anastomosis was made be-
tween the artery (carotid and femoral) and vein (arteriovenous (AV)
shunt). To decrease £ow (n = 24), the artery (carotid and femoral) was
partially ligated until £ow was reduced to at least 60% of the initial
value. Rabbits were terminated at 1, 2, 7 or 21 days after operation.
At operation and termination, blood £ow was measured using a trans-
it time £ow probe (Transonic System Inc.). To determine arterial
inner diameter before and after the operation and at termination,
an intravascular ultrasound catheter (30 MHz Du-Med, Rotterdam,
The Netherlands) was placed parallel to the artery submerged in saline
(i.e. extravascular ultrasound = EVUS). Before EVUS, the artery was
maximally dilated by embedding for 3 min in a saline solution con-
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taining 5 mg/ml papaverin. The contra-lateral artery was used as a
control. The measured arterial segments were at least 1.5 cm away
from the surgical intervention area. Sham operations (n = 3) were
performed as described but without ligation or AV shunt.
The investigation conforms with the Guide for the Care and Use of
Laboratory Animals (NIH publication No. 85-23, 1985) and was ap-
proved by the ethical committee on animal experiments of the Uni-
versity Medical Center, Utrecht, The Netherlands.
2.2. Extraction of RNA and protein
After collection, the frozen arteries were ground with a pestle and
mortar under liquid nitrogen until a ¢ne powder was obtained. Total
RNA and protein were isolated by adding 1 ml Tripure Isolation
Reagent (Boehringer) to the ground artery (approximately 40 mg).
RNA and protein isolation was performed according to the manu-
facturer.
2.3. Zymography
Protein samples (9 Wg) were separated on a sodium dodecyl sulfate^
polyacrylamide gel containing 1 mg/ml gelatin (Sigma) in the 8%
running gel. After running, the gel was washed 2U15 min in 2.5%
Triton X-100 and incubated overnight at 37‡C in Brij solution (0.05
M Tris^HCl pH 7.4, 0.01 M CaCl2, 0.05% Brij 35 (Sigma)). The gel
was then stained with Coomassie blue (25% methanol, 15% acetic
acid, 0.1% Coomassie blue) for 1 h at room temperature (RT), fol-
lowed by a destaining in 25% methanol/15% acetic acid for approx-
imately 30 min. The di¡erent MMPs were identi¢ed by size and in co-
migration with its recombinant protein (rhMMP2, Accurate Chem.
and Scienti¢c Corp., NY, USA).
The amount of inactive MMP2 (72 kDa) and activated MMP2 (64
kDa) was determined using the Gel Doc 1000 system. Activated
MMP2 was expressed as the relative amount of total (inactive plus
active) MMP2.
2.4. cDNA synthesis and semi-quantitative PCR
Total RNA (500 ng) was converted to cDNA using the Ready to
GoYou Prime system (Pharmacia) with 1 Wl (200 ng) hexanucleotide
according to the instructions of the manufacturer. After cDNA syn-
thesis, the sample was diluted with DEPC-treated water to 540 Wl. For
PCR ampli¢cation of speci¢c cDNAs, reactions (25 Wl) contained 200
WM dNTP, 1UPCR reaction bu¡er (Pharmacia), 2.5 U Taq DNA
polymerase (Pharmacia), 1 WM of each primer and 20 Wl diluted
cDNA. A typical PCR started with a 2 min incubation at 94‡C, 30
s at 94‡C, 30 s at 60‡C or 62‡C and 30 s at 72‡C followed by an
extension of 7 min at 72‡C for 25^33 cycles. 10 Wl of each reaction was
electroforesed through 8% polyacrylamide gels. After running, the gel
was stained with EtBr and the amount of EtBr staining of the PCR
product was determined with the Gel Doc 1000 system. Control ex-
periments were performed to determine the range of PCR cycles over
which ampli¢cation e⁄ciency remained constant and to demonstrate
that the amount of PCR product was directly proportional to the
amount of input cDNA. PCR ampli¢cation on total RNA which
had not been reverse-transcribed showed that genomic DNA was
not present (data not shown). Data are presented as relative changes
in the abundance of mRNA corrected for the amount of L-actin
mRNA, as an internal standard, present in the samples. The identity
of the cDNA ampli¢ed was con¢rmed by subcloning the ampli¢ed
cDNAs into PGEM-T Easy (Promega) and then sequencing the in-
serts (Amersham, Sequenase 2.0).
The following oligonucleotides were used as primers.
Rabbit L-actin: 5P primer 5P-GGCATGGCTTTATTCGTGTT-3P ;
3P primer 5P-CACCTTCACCGTTCCAGTTT-3P ; rabbit furin: 5P
primer 5P-CCATCCAGGCTGGTTTTGTA-3P ; 3P primer 5P-GTCC-
ATTAAATAGAACCAACAATGC-3P ; rabbit MT1-MMP: 5P primer
5P-GTTGAATTTCCAGTATTTGTTCCC-3P ; 3P primer 5P-ACATC-
AAAGTGTGGGAAGGC-3P.
2.5. Immunohistochemistry
Frozen arterial segments embedded in Tissuetec (Akora) were cut
into 5 Wm sections and ¢xed for 10 min in acetone containing 0.03%
H2O2 to block endogenous peroxidase. Sections were then incubated
with 10 Wg/ml mouse anti-MT1-MMP monoclonal antibody (mAb)
(Campro), 10 Wg/ml mouse IgG1/k or RAM11 (Dako) overnight at
4‡C in phosphate-bu¡ered saline (PBS)/bovine serum albumin (BSA)
0.1%. After overnight incubation the sections were rinsed in PBS
(three times for 5 min) and incubated with 1 Wg/ml horse anti-mouse
biotin Ab (Dakopatts) in PBS/BSA 1% containing 1% normal rabbit
serum (1 h, RT). Next, the sections were rinsed in PBS (three times for
5 min) and incubated with streptavidin peroxidase (Dako) in PBS/
BSA 1% containing 1% normal rabbit serum (1 h, RT) and sequen-
tially treated with a sodium acetate bu¡er containing 0.4 mg/ml
3-amino 9-ethylcarbazole substrate for 15 min.
2.6. Statistical analysis
Statistical analysis of the results was performed by the Wilcoxon
matched pairs signed rank test. Data are presented as mean þ S.E.M.
Di¡erences were considered as statistically signi¢cant for P-values less
then 0.05.
Fig. 1. Blood £ow and arterial remodeling after AV shunting or partial ligation of the carotid and femoral rabbit artery 1, 2, 7 and 21 days
after operation. A: Increase in blood £ow after AV shunting compared to contra-lateral control artery. B: Decrease in blood £ow after partial
ligation compared to contra-lateral artery. C: Remodeling of the artery after £ow increase. D: Remodeling of the artery after £ow decrease in
relative arterial diameter changes compared to the contra-lateral control artery. n = 10^18 per time point, *P6 0.05 compared with control val-
ues (ratio = 1).
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3. Results
3.1. Arterial £ow and remodeling after AV shunting and partial
ligation
The increase in £ow by AV shunting and the decrease in
£ow by partial ligation are depicted in Fig. 1A,B. After creat-
ing the AV shunt, £ow increased progressively to 15-fold com-
pared to the contra-lateral artery. Partial ligation resulted in a
2^3-fold decrease in both artery types. Since £ow changes
were similar in both arteries, the data were pooled. At all
time points, the change in £ow of both arteries was signi¢cant.
Changes in arterial diameter after £ow increase and £ow
decrease are shown in Fig. 1C,D. Arterial diameter changes
were similar in the femoral and carotid arteries. One day after
£ow increase, arterial size did not change. At 2 days after £ow
increase, arterial diameter increased compared to the contra-
lateral artery (25 þ 4%). Arterial diameter increased further up
to 42 þ 4% (Fig. 1C) at day 21. At 1 and 2 days after £ow
decrease, the arterial diameter did not change signi¢cantly. A
signi¢cant decrease in arterial diameter was found after 7 days
(334 þ 7%) and increased slightly at 21 days (339 þ 10%)
compared to the contra-lateral artery (Fig. 1D).
3.2. Furin, MT1-MMP expression and MMP2 activation
To explore if arterial remodeling was associated with furin
and MT1-MMP expression, we used semi-quantitative PCR
to measure furin and MT1-MMP mRNA levels at the di¡er-
ent time points after £ow increase or decrease (Fig. 2A,B).
Gelatin zymography was used to determine MMP2 activation
(Fig. 2C,D). In each gelatin zymography gel, MMP2 was
identi¢ed in size and in co-migration with its recombinant
protein.
After sustained £ow increase, furin mRNA ratios (increased
£ow/control) were signi¢cantly higher at 1 day (1.8), declined
at day 2 (1.6), and returned to control values at days 7 and 21.
MT1-MMP mRNA ratios (increased £ow/control) were sig-
ni¢cantly increased at day 1 and day 2 (1.8 and 3.3 respec-
tively) and remained high at days 7 and 21 (2.4 and 3.2 re-
spectively). Between the £ow-increased and contra-lateral
control artery, the relative amount of activated MMP2
showed a signi¢cant di¡erence at day 7 (1.5) and day 21 (5.6).
After sustained £ow decrease, furin mRNA ratios (de-
creased £ow/control) did not alter at days 1 and 2 and were
only higher (2.4) after 7 days sustained decrease in blood £ow.
At day 21, furin mRNA ratios seemed to decline again (1.9).
MT1-MMP mRNA ratios stayed also at baseline at 1 and
2 days and tended to increase at day 7 (1.6) and day 21 (1.8).
Comparison of the relative amount of activated MMP2 be-
tween the £ow-decreased and control artery showed a signi¢-
cant di¡erence at day 7 (1.4) and day 21 (2.1). No di¡erences
were found in furin, MT1-MMP levels and MMP2 activation
in the sham-operated arteries.
3.3. Localization of MT1-MMP in the arterial wall after £ow
change
To identify the arterial layers in which the proprotein^
MT1-MMP axis is present, we stained sections of a femoral
artery after £ow increase with an Ab directed against MT1-
MMP (Fig. 3). A strong staining was observed in the medial
and adventitial layer of the artery (Fig. 3A) and no staining at
all with an isotypic control Ab (Fig. 3B).
No macrophages were detected with the acid phosphatase
method [18] as well as with the RAM11 Ab (results not
shown).
4. Discussion
Proprotein activation by furin is important in several fun-
damental biological processes like cellular signaling, embryo-
genesis and extracellular matrix composition [19]. The ¢nding
Fig. 2. Furin and MT1-MMP mRNA levels and MMP2 activation, 1, 2, 7 and 21 days after sustained change in blood £ow. A: Ratio of furin
(white bars) and MT1-MMP (black bars) mRNA levels between operated and contra-lateral control arteries during £ow increase and (B) dur-
ing £ow decrease. (C) Relative amount of activated MMP2 of total MMP2 in £ow-increased (black bars) and contra-lateral control arteries
(white bars) and (D) in £ow-decreased (black bars) and contra-lateral arteries (white bars). n = 10^18 per time point, *P6 0.05.
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that proprotein convertase-activated MT1-MMP is the in vivo
activator of MMP2 in mice [11] showed that the amount of
activated MMP2 can be used to monitor MT1-MMP activa-
tion and identi¢es the proprotein convertases as an important
target for local intervention in tissue remodeling. This idea is
strengthened by the observation that MMP inhibition blocks
constrictive arterial remodeling after balloon dilation [8,9]. A
recent in vitro study demonstrates the existence of a propro-
tein convertase^MT1-MMP^MMP2 axis that can regulate
extracellular matrix remodeling. Moreover, it identi¢es the
proprotein convertases furin and PC6 as the major processing
enzymes for MT1-MMP although a minor role for PC7 and
proprotein convertase independent MT1-MMP activation
cannot be excluded [15]. However, the role of this propro-
tein^MMP axis in remodeling of adult arteries, an important
determinant of arterial lumen loss during atherosclerosis [4,5]
and after balloon angioplasty [1^3], has not yet been de-
scribed.
In this study, arterial remodeling was induced in rabbits via
sustained increase or decrease in blood £ow. The sustained
£ow increase (5^15-fold increase) resulted in arterial enlarge-
ment after 2 days sustained £ow increase. Flow decrease re-
sulted in arterial shrinkage after 7 days sustained £ow de-
crease. Similarly, expression of furin and MT1-MMP
mRNA was induced before and at the onset of arterial en-
largement. At the onset of arterial shrinkage (day 7) also furin
mRNA was increased. During arterial enlargement, MMP2
activation was almost doubled at day 7 and increased 6-fold
at day 21, while during arterial shrinkage MMP2 activation
was doubled at days 7 and 21.
The increase in furin and MT1-MMP mRNA levels also
revealed that the furin^MT1-MMP axis was upregulated pre-
ceding and during arterial enlargement and shrinkage. Strong
correlations are found between MT1-MMP mRNA levels and
MMP2 activation [20] on one hand and furin mRNA and
transforming growth factor (TGF) L1 activation on the other
hand [21]. This implies that furin and MT1-MMP activity are
transcriptionally regulated and that furin mRNA levels as well
as MT1-MMP mRNA levels are good indicators for furin and
MT1-MMP activity. Similar to the MMP2 activation and
arterial diameter, the increase in furin and MT1-MMP
mRNA is earlier and higher after £ow increase (10^15-fold
increase in blood £ow) than after £ow decrease (2^3-fold de-
crease in blood £ow). This suggests that regulation of MMP2
activation in arterial remodeling depends on the degree of
shear stress change although a role for the direction of arterial
remodeling cannot be excluded. Shear stress dependent regu-
lation might involve TGFL1 which is regulated by £uid shear
stress [22] and stimulates furin mRNA expression [21].
After £ow increase and decrease, arterial remodeling occurs
without in£ammation and neointima formation and makes
this an ideal model to study arterial remodeling only. MT1-
MMP staining suggests that both media (smooth muscle cells)
and adventitia (¢broblasts) are involved in the process of
MMP2 activation. These cells are also the major collagen
producing cells of the arterial wall [23] and can therefore
degrade and synthesize collagen to reshape the collagen arte-
rial skeleton.
In conclusion, these data show that the furin^MT1-MMP^
MMP2 axis is upregulated before and during both modes of
arterial remodeling and open the possibility to use local deliv-
ery of a synthetic furin inhibitor [24] or a protein-based pro-
protein convertase (furin and PC6) blocker [25] to intervene in
pathological arterial remodeling.
Acknowledgements: This work is supported by the Netherlands Orga-
nization for Scienti¢c Research (NWO), Grants 902-16-239 and 902-
26-213, and the Netherlands Heart Foundation (NHS), Grant 99-209.
References
[1] Post, M.J., Borst, C. and Kuntz, R.E. (1994) Circulation 89,
2816^2821.
[2] Di Mario, C., Gil, R., Camenzind, E., Ozaki, Y., von Birgelen,
C., Umans, V., de Jaegere, P., de Feyter, P.J., Roelandt, J.R. and
Serruys, P.W. (1995) Am. J. Cardiol. 75, 772^777.
[3] Mintz, G.S., Popma, J.J., Hong, M.K., Pichard, A.D., Kent,
K.M., Satler, L.F. and Leon, M.B. (1996) Am. J. Cardiol. 78,
18^22.
[4] Glagov, S., Weisenberg, E., Zarins, C.K., Stankunavicius, R. and
Kolettis, G.J. (1987) N. Engl. J. Med. 316, 1371^1375.
[5] Pasterkamp, G., Wensing, P.J., Post, M.J., Hillen, B., Mali, W.P.
and Borst, C. (1995) Circulation 91, 1444^1449.
[6] Langille, B.L., Bendeck, M.P. and Keeley, F.W. (1989) Am. J.
Physiol. 256, H931^H939.
[7] Abbruzzese, T.A., Guzman, R.J., Martin, R.L., Yee, C., Zarins,
C.K. and Dalman, R.L. (1998) Surgery 124, 328^334.
[8] de Smet, B.J., de Kleijn, D., Hanemaaijer, R., Verheijen, J.H.,
Robertus, L., van Der Helm, Y.J., Borst, C. and Post, M.J.
(2000) Circulation 101, 2962^2967.
[9] Sierevogel, M.J., Pasterkamp, G., Velema, E., de Jaegere, P.P.,
de Smet, B.J., Verheijen, J.H. and de Kleijn, D.P. (2001) Circu-
lation 103, 302^307.
[10] Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer,
M., Kuznetsov, S.A., Mankani, M., Robey, P.G., Poole, A.R.,
Pidoux, I., Ward, J.M. and Birkedal-Hansen, H. (1999) Cell 99,
81^92.
[11] Zhou, Z., Apte, S.S., Soininen, R., Cao, R., Baaklini, G.Y.,
Rauser, R.W., Wang, J., Cao, Y. and Tryggvason, K. (2000)
Proc. Natl. Acad. Sci. USA 97, 4052^4057.
[12] Kinoshita, T., Sato, H., Takino, T., Itoh, M., Akizawa, T. and
Seiki, M. (1996) Cancer Res. 56, 2535^2538.
[13] Pei, D. and Weiss, S.J. (1995) Nature 375, 244^247.
[14] Santavicca, M., Noel, A., Angliker, H., Stoll, I., Segain, J.P.,
Anglard, P., Chretien, M., Seidah, N. and Basset, P. (1996) Bio-
chem. J. 315, 953^958.
[15] Yana, I. and Weiss, S.J. (2000) Mol. Biol. Cell 11, 2387^2401.
Fig. 3. A: Immunohistochemistry of rabbit femoral artery, 7 days after sustained increase in blood £ow using mAb against MT1-MMP or (B)
an isotypic control Ab. EEL is the external elastic lamina between the arterial medial and adventitial layer. Bar is 50 Wm.
FEBS 25035 6-7-01
D.P.V. de Kleijn et al./FEBS Letters 501 (2001) 37^4140
[16] Galis, Z.S., Sukhova, G.K., Kranzhofer, R., Clark, S. and Libby,
P. (1995) Proc. Natl. Acad. Sci. USA 92, 402^406.
[17] Bendeck, M.P., Irvin, C. and Reidy, M.A. (1996) Circ. Res. 78,
38^43.
[18] Laman, J.D., de Smet, B.J., Schoneveld, A. and van Meurs, M.
(1997) Immunol. Today 18, 272^277.
[19] Molloy, S.S., Anderson, E., Jean, F. and Thomas, G. (1999)
Trends Cell. Biol. 9, 28^35.
[20] Iki, K., Tsutsumi, M., Kido, A., Sakitani, H., Takahama, M.,
Yoshimoto, M., Motoyama, M., Tatsumi, K., Tsunoda, T. and
Konishi, Y. (1999) Carcinogenesis 20, 1323^1329.
[21] Blanchette, F., Day, R., Dong, W., Laprise, M.H. and Dubois,
C.M. (1997) J. Clin. Invest. 99, 1974^1983.
[22] Ohno, M., Cooke, J.P., Dzau, V.J. and Gibbons, G.H. (1995)
J. Clin. Invest. 95, 1363^1369.
[23] Shi, Y., O’Brien, J.E., Ala-Kokko, L., Chung, W., Mannion, J.D.
and Zalewski, A. (1997) Circulation 95, 997^1006.
[24] Maquoi, E., Noel, A., Frankenne, F., Angliker, H., Murphy, G.
and Foidart, J.M. (1998) FEBS Lett. 424, 262^266.
[25] Jean, F., Stella, K., Thomas, L., Liu, G., Xiang, Y., Reason, A.J.
and Thomas, G. (1998) Proc. Natl. Acad. Sci. USA 95, 7293^
7298.
FEBS 25035 6-7-01
D.P.V. de Kleijn et al./FEBS Letters 501 (2001) 37^41 41
